Author:
Jordheim Lars Petter,Galmarini Carlos M.,Dumontet Charles
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference56 articles.
1. Antonsson BE, Avramis VI, Nyce J, Holcenberg JS (1987) Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1. Cancer Res 47:3672–3678
2. Beausejour CM, Gagnon- J, Primeau M, Momparler RL (2002) Cytotoxic activity of 2′, 2′-difluorodeoxycytidine, 5-aza-2′-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene. Biochem Biophys Res Commun 293:1478–1484
3. Bergman AM, Eijk PP, Ruiz van Haperen VW, Smid K, Veerman G, Hubeek I, van den Ijssel P, Ylstra B, Peters GJ (2005) In vivo Induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant. Cancer Res 65:9510–9516
4. Bergman AM, Pinedo HM, Peters GJ (2002) Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine). Drug Resist Updat 5:19–33
5. Bouffard DY, Laliberte J, Momparler RL (1993) Kinetic studies on 2′, 2′-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase. Biochem Pharmacol 45:1857–1861
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献